KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 112 filers reported holding KEROS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $952,383 | -13.2% | 29,874 | +9.4% | 0.00% | 0.0% |
| Q2 2023 | $1,097,195 | -0.4% | 27,307 | +5.9% | 0.00% | 0.0% |
| Q1 2023 | $1,101,404 | +14.1% | 25,794 | +28.3% | 0.00% | 0.0% |
| Q4 2022 | $965,267 | +276.7% | 20,104 | +195.2% | 0.00% | – |
| Q3 2022 | $256,230 | -28.2% | 6,811 | +3.7% | 0.00% | – |
| Q1 2022 | $357,005 | -25.6% | 6,565 | -20.0% | 0.00% | – |
| Q4 2021 | $480,000 | +42.4% | 8,209 | -3.5% | 0.00% | – |
| Q3 2021 | $337,000 | -12.0% | 8,508 | -5.6% | 0.00% | – |
| Q2 2021 | $383,000 | -17.8% | 9,012 | +18.9% | 0.00% | – |
| Q1 2021 | $466,000 | -14.5% | 7,579 | -2.0% | 0.00% | -100.0% |
| Q4 2020 | $545,000 | – | 7,731 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,382,641 | $85,102,000 | 10.19% |
| Consonance Capital Management LP | 890,209 | $54,792,000 | 5.84% |
| CHI Advisors LLC | 400,468 | $24,649,000 | 4.94% |
| Fairmount Funds Management LLC | 109,333 | $6,729,000 | 2.84% |
| VR Adviser, LLC | 372,306 | $22,915,000 | 2.49% |
| Opaleye Management Inc. | 157,500 | $9,694,000 | 1.42% |
| Darwin Global Management, Ltd. | 86,887 | $5,348,000 | 1.05% |
| Orbimed Advisors | 1,679,417 | $103,368,000 | 0.97% |
| Nantahala Capital Management | 460,372 | $28,336,000 | 0.83% |
| Eventide Asset Management | 427,414 | $26,307,000 | 0.39% |